Programming T cell killers for an HIV cure: Teach the new dogs new tricks and let the sleeping dogs lie

Kellie Smith, Robbie B. Mailliar, Charles R. Rinaldo

Research output: Contribution to journalArticle

Abstract

Despite the success of combination antiretroviral therapy (cART), a latent viral reservoir persists in HIV-1-infected persons. Unfortunately, endogenous cytotoxic T lymphocytes (CTLs) are unable to control viral rebound when patients are removed from cART. A "kick and kill" strategy has been proposed to eradicate this reservoir, whereby infected T cells are induced to express viral proteins via latency-inducing drugs followed by their elimination by CTLs. It has yet to be determined if stimulation of existing HIV-1-specific CTL will be sufficient, or if new CTLs should be primed from naïve T cells. In this review, we propose that dendritic cells (DCs), the most potent antigen presenting cells, act as dog trainers and can induce T cells (the dogs) to do magnificent tricks. We propose the hypothesis that an HIV-1 cure will require targeting of naïve T cells and will necessitate "teaching new dogs new tricks" while avoiding activation of potentially dysfunctional endogenous memory CTLs (letting the sleeping dogs lie).

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalForum on Immunopathological Diseases and Therapeutics
Volume6
Issue number1-2
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

T-cells
Cytotoxic T-Lymphocytes
HIV
Dogs
T-Lymphocytes
HIV-1
Viral Proteins
Antigen-Presenting Cells
Dendritic Cells
Teaching
Therapeutics
Pharmaceutical Preparations
Chemical activation
Data storage equipment

Keywords

  • CTL
  • Dendritic cells
  • HIV-1
  • Immunotherapy

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Genetics

Cite this

Programming T cell killers for an HIV cure : Teach the new dogs new tricks and let the sleeping dogs lie. / Smith, Kellie; Mailliar, Robbie B.; Rinaldo, Charles R.

In: Forum on Immunopathological Diseases and Therapeutics, Vol. 6, No. 1-2, 2015, p. 67-77.

Research output: Contribution to journalArticle

@article{8d8acdfd14424f338cdb3e5043fccbd6,
title = "Programming T cell killers for an HIV cure: Teach the new dogs new tricks and let the sleeping dogs lie",
abstract = "Despite the success of combination antiretroviral therapy (cART), a latent viral reservoir persists in HIV-1-infected persons. Unfortunately, endogenous cytotoxic T lymphocytes (CTLs) are unable to control viral rebound when patients are removed from cART. A {"}kick and kill{"} strategy has been proposed to eradicate this reservoir, whereby infected T cells are induced to express viral proteins via latency-inducing drugs followed by their elimination by CTLs. It has yet to be determined if stimulation of existing HIV-1-specific CTL will be sufficient, or if new CTLs should be primed from na{\"i}ve T cells. In this review, we propose that dendritic cells (DCs), the most potent antigen presenting cells, act as dog trainers and can induce T cells (the dogs) to do magnificent tricks. We propose the hypothesis that an HIV-1 cure will require targeting of na{\"i}ve T cells and will necessitate {"}teaching new dogs new tricks{"} while avoiding activation of potentially dysfunctional endogenous memory CTLs (letting the sleeping dogs lie).",
keywords = "CTL, Dendritic cells, HIV-1, Immunotherapy",
author = "Kellie Smith and Mailliar, {Robbie B.} and Rinaldo, {Charles R.}",
year = "2015",
doi = "10.1615/ForumImmunDisTher.2016014160",
language = "English (US)",
volume = "6",
pages = "67--77",
journal = "Forum on Immunopathological Diseases and Therapeutics",
issn = "2151-8017",
publisher = "Begell House Inc.",
number = "1-2",

}

TY - JOUR

T1 - Programming T cell killers for an HIV cure

T2 - Teach the new dogs new tricks and let the sleeping dogs lie

AU - Smith, Kellie

AU - Mailliar, Robbie B.

AU - Rinaldo, Charles R.

PY - 2015

Y1 - 2015

N2 - Despite the success of combination antiretroviral therapy (cART), a latent viral reservoir persists in HIV-1-infected persons. Unfortunately, endogenous cytotoxic T lymphocytes (CTLs) are unable to control viral rebound when patients are removed from cART. A "kick and kill" strategy has been proposed to eradicate this reservoir, whereby infected T cells are induced to express viral proteins via latency-inducing drugs followed by their elimination by CTLs. It has yet to be determined if stimulation of existing HIV-1-specific CTL will be sufficient, or if new CTLs should be primed from naïve T cells. In this review, we propose that dendritic cells (DCs), the most potent antigen presenting cells, act as dog trainers and can induce T cells (the dogs) to do magnificent tricks. We propose the hypothesis that an HIV-1 cure will require targeting of naïve T cells and will necessitate "teaching new dogs new tricks" while avoiding activation of potentially dysfunctional endogenous memory CTLs (letting the sleeping dogs lie).

AB - Despite the success of combination antiretroviral therapy (cART), a latent viral reservoir persists in HIV-1-infected persons. Unfortunately, endogenous cytotoxic T lymphocytes (CTLs) are unable to control viral rebound when patients are removed from cART. A "kick and kill" strategy has been proposed to eradicate this reservoir, whereby infected T cells are induced to express viral proteins via latency-inducing drugs followed by their elimination by CTLs. It has yet to be determined if stimulation of existing HIV-1-specific CTL will be sufficient, or if new CTLs should be primed from naïve T cells. In this review, we propose that dendritic cells (DCs), the most potent antigen presenting cells, act as dog trainers and can induce T cells (the dogs) to do magnificent tricks. We propose the hypothesis that an HIV-1 cure will require targeting of naïve T cells and will necessitate "teaching new dogs new tricks" while avoiding activation of potentially dysfunctional endogenous memory CTLs (letting the sleeping dogs lie).

KW - CTL

KW - Dendritic cells

KW - HIV-1

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=84976618207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976618207&partnerID=8YFLogxK

U2 - 10.1615/ForumImmunDisTher.2016014160

DO - 10.1615/ForumImmunDisTher.2016014160

M3 - Article

C2 - 28344852

AN - SCOPUS:84976618207

VL - 6

SP - 67

EP - 77

JO - Forum on Immunopathological Diseases and Therapeutics

JF - Forum on Immunopathological Diseases and Therapeutics

SN - 2151-8017

IS - 1-2

ER -